rxstat › Shortages › Urofollitropin For Injection

Urofollitropin For Injection shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Urofollitropin For Injection products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 1
Reports on file
2

Reports by product

Resolved
BRAVELLE
75 IU's per vial · Powder for Injection · FERRING INC
DIN 02268140 · ended Jul 18, 2019 · Disruption of the manufacture of the drug.
Discontinued
BRAVELLE
FERRING INC
DIN 02268140

What's happening

One or more Urofollitropin For Injection products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Urofollitropin For Injection is classified under “GONADOTROPHINS AND OTHER OVULATION STIMULANTS” (ATC G03GA).

Recent changes

Common questions

When will Urofollitropin For Injection be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Urofollitropin For Injection in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (gonadotrophins and other ovulation stimulants)

Partial shortageChoriogonadotropin Alfa1 of 2 reported products affected · est. return Sep 30, 2026No current shortageChorionic GonadotropinDiscontinuedClomiphene0 of 2 reported products affectedNo current shortageFollitropin AlfaNo current shortageLutropin Alfa

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.